21139 ⎘
Medicinal preparations containing antigens or antibodies Allergens
Methods of oral immunotherapy
#302Composition and method for reducing allergic response
#303PSEUDO-VIRAL PARTICLES AND USES OF SAME
#304Compositions and methods relating to the treatment of diseases
#305Method and system for protecting honey bees from fipronil pesticides
#306METHOD FOR THE PRODUCTION OF HYDROLYZED ALLERGENS
#307Treatment of peanut allergy
#308MODULAR NANODEVICES FOR SMART ADAPTABLE VACCINES
#309TOFACITINIB AS VACCINATION IMMUNE MODULATOR
#310Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#311SOYBEAN ALLERGY ANTIGEN
#312Treatment of immune disease by mucosal delivery of antigens using genetically modified
#313METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#314TOLERANCE THERAPEUTIC FOR TREATING POLYPEPTIDE INDUCED IMMUNE ACTIVATION
#315Mixed allergen compositions and methods for using the same
#316Mixed allergen compositions and methods for using the same
#317Immunotherapy for the treatment of allergic disease
#318Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
#319MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
#320IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy
#321Epitopes Related To Coeliac Disease
#322Skin microenvironment targeted delivery for promoting immune and other responses
#323Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
#324Allergen desensitization method
#325MATERIALS AND METHODS FOR MODULATING IMMUNE RESPONSES
#326Human antibodies to Fel d1 and methods of use thereof
#327Glycotargeting therapeutics
#328Antigens and T cell epitopes from cockroach and methods of making and using same
#329Modulators of the function of the core domain of annexins, and uses thereof in autoimmune and/or cancer therapy
#330Compositions and methods relating to the treatment of diseases
#331Nanoallergens and uses thereof
#332Glycotargeting therapeutics
#333Dermatophagoides farinae protein
#334Microbial consortium and uses thereof
#335METHOD FOR THE PRODUCTION OF HYDROLYZED ALLERGEN
#336Treatment of insect bite hypersensitivity
#337Compositions against cat allergy
#338TOLERANCE THERAPEUTIC FOR TREATING POLYPEPTIDE INDUCED ALLERGY
#339Methods of using a vaccine composition containing synthetic adjuvant
#340Assay for the diagnosis of peanut allergy
#341Vaccine composition containing synthetic adjuvant
#342Immunogenic protein Pas n 1 from Bahia grass pollen
#343Process for producing an allergen extract
#344Process for Producing an Allergen Extract
#345METHODS OF MANUFACTURE OF NUT FLOURS AND FORMULATIONS FOR ORAL IMMUNOTHERAPY
#346IMMUNOGENIC COMPOSITION
#347Quail egg allergy antigen
#348Transdermal patch with separated regions for delivery of immunomodulators
#349Oral food challenge meal formulations
#350Modular antigen transportation molecules and uses therof
#351Vaccine adjuvant composition comprising inulin particles
#352ALLERGY-SPECIFIC IMMUNOTHERAPY COMPOSITIONS FOR USE IN THE TREATMENT OF HOUSE-DUST MITE ALLERGY
#353Allergy vaccine composition
#354PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS
#355METHOD OF TREATING PATIENTS WITH NON-IgE MEDIATED HYPERSENSITIVITIES TO ENVIRONMENTAL ALLERGENS
#356Epitopes from allergen proteins and methods and uses for immune response modulation
#357POLYESTER POLYMER MATRICES FOR THE DELIVERY OF ALLERGENS
#358Subunit vaccine delivery platform for robust humoral and cellular immune responses
#359IMMUNIZING PEPTIDE, METHOD FOR PRODUCING IMMUNIZING PEPTIDE, PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE CONTAINING SAME, AND METHOD FOR TREATING IMMUNE DISEASE
#360DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERS
#361Manufacture of peanut formulations for oral desensitization
#362Baby food products containing allergenic proteins and methods of delivering same
#363Nucleic acids for treatment of allergies
#364Sialylated fetuin-A as a marker of immunotherapy efficacy
#365Allergen dosage form
#366NUTRITIONAL SUPPLEMENTS AND METHODS FOR PRIMARY PREVENTION OF FOOD ALLERGIES
#367TOLEROGENIC COMPOSITIONS AND METHODS
#368Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
#369USE OF SUPERANTIGENS FOR IMPROVING MUCOSAL ALLERGEN SPECIFIC IMMUNOTHERAPY IN HUMAN BEINGS
#370Methods and compositions for attenuating allergenicity in protein products
#371Treatment of allergies and autoimmune diseases
#372Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
#373Cytokine-based fusion proteins for treatment of immune disorders
#374Detection of an immune response
#375Modified virus-like particles of CMV
#376NUCLEIC ACIDS FOR TREATMENT OF PEANUT ALLERGIES
#377METHODS AND COMPOSITIONS INVOLVING RECOMBINANT HYPOALLERGENS
#378EPITOPES RELATED TO COELIAC DISEASE
#379GLYCOTARGETING THERAPEUTICS
#380Lipid vesicle compositions and methods of use
#381Immunostimulating Polyphosphazene Compounds
#382Standardized Subcutaneous Allergen Immunotherapy
#383Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
#384USE OF SUPERANTIGENS FOR IMPROVING MUCOSAL ALLERGEN SPECIFIC IMMUNOTHERAPY IN NON-HUMAN MAMMALS
#385Allergen
#386Human antibodies to Fel d1 and methods of use thereof
#387Methods for effectively and rapidly desensitizing allergic patients
#388Macadamia allergen
#389Peptide for Protection of Allergic Respiratory Disorders
#390PHARMACEUTICAL COMBINATIONS FOR IMMUNOTHERAPY
#391Immunotherapy composition and use thereof
#392Synergistic nutritional compositions and uses thereof
#393Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
#394Compositions for delivery of food allergens to the stomach
#395RNA vaccines
#396Allergen desensitization method
#397Polymeric particles, method for cytosolic delivery of cargo, methods of making the particles
#398Mixed allergen compositions and methods for using the same
#399Mixed allergen compositions and methods for using the same
#400Mixed allergen compositions and methods for using the same
#401Allergy inhibitor compositions and kits and methods of using the same
#402Extracellular hyaluronidase from
#403HSP-FREE ALLERGEN PREPARATION
#404Induction of mucosal tolerance to antigens
#405Modular antigen transportation molecules and uses thereof in animals
#406SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION
#407Nanoparticle compositions
#408COMPOSITIONS AND METHODS FOR INTRADERMAL VACCINE DELIVERY
#409Mixed allergen compositions and methods for using the same
#410Compositions for antigen-specific induction of tolerance
#411INDIVIDUALLY CUSTOMIZED ALLERGY CREAM FOR INDIVIDUAL PATIENT PROFILE
#412Peanut formulations and uses thereof
#413Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
#414ALLERGY PREVENTING DOSAGE CONTROLLED FOOD PACKETS
#415Interleukin-2 for treating food allergy
#416Glycotargeting therapeutics
#417MILK-BASED PROTEIN HYDROLYSATES AND INFANT FORMULAE AND NUTRITIONAL COMPOSITIONS MADE THEREOF
#418Human antibodies to fel D1 and methods of use thereof
#419Immunotherapeutic composition and uses thereof
#420Predilution sets for distributing antigens
#421COMPOSITIONS WITH REDUCED DIMER FORMATION
#422C1q as a therapeutic agent of allergy and/or asthma
#423Therapeutic treatment kit for allergies based on DNA profiles
#424USE OF AUTOINJECTOR FOR DISTRIBUTING ANTIGENS TO THE PUBLIC
#425Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy
#426CARBOHYDRATE-MODIFIED PARTICLES AND PARTICULATE FORMULATIONS FOR MODULATING AN IMMUNE RESPONSE
#427Animal models and therapeutic molecules
#428Method and system for treating cancer cachexia
#429ANTIGEN-SPECIFIC IMMUNOTHERAPY USING TOLERIZING LIPOSOMES
#430Method and means for diagnosing and treating allergy
#431EPICUTANEOUS IMMUNOREBALANCING
#432IMMUNOMODULATING COMPOSITIONS AND METHODS OF USE THEREOF
#433METHOD OF PREVENTING ALLERGIES
#434Allergen dosage form
#435Bacterial compositions and methods of use thereof for treatment of immune system disorders
#436Immunomodulatory compositions and methods of use thereof
#437Programming of cells for tolerogenic therapies
#438Glucopyranosyl Lipid A and Allergen Formulations For Sublingual Administration
#439HEAT-TREATED FORMULATION OF BIFIDOBACTERIUM LACTIS NCC 2818 REDUCES ALLERGIC MANIFESTATIONS
#440Lipid vesicle compositions and methods of use
#441Composition for oral delivery of bioactive agents
#442Tolerogenic synthetic nanocarriers for allergy therapy
#443Epitopes related to coeliac disease
#444Nucleic acids for treatment of allergies
#445Methods of treating allergies and autoimmune diseases with homogenate of axenic
#446COMPOSITIONS AND METHODS FOR TOLERIZING THE IMMUNE SYSTEM TO ALLERGENS
#447Peptide combinations and uses thereof in treating dust mite allergy
#448Tolerogenic synthetic nanocarriers
#449Glycotargeting therapeutics
#450COMPOSITIONS AND METHODS FOR TOLERIZING CELLULAR SYSTEMS
#451Mixed allergen compositions and methods for using the same
#452COMPOSITIONS AND METHODS RELATED TO OAT SENSITIVITY
#453Method of inducing tolerance to an allergen
#454Toothpaste for delivery of allergens to oral mucosa
#455PHL P 5A DERIVATIVES HAVING REDUCED ALLERGENEITY AND RETAINED T-CELL REACTIVITY
#456Methods, Articles and Kits for Allergic Desensitization via the Oral Mucosa
#457Immunogenic peptides and their use in immune disorders
#458NUCLEIC ACIDS FOR TREATMENT OF ALLERGIES
#459Immunotherapy composition and use thereof
#460Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
#461Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
#462Detection of an immune response
#463Recombinantly produced allergens
#464Nanoparticle compositions
#465Immunostimulating polyphosphazene compounds
#466Allergen peptide fragments and use thereof for treatment of birch pollen allergies
#467Horse allergen and methods
#468Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
#469Immunogenic complex for vaccination and method for the production thereof
#470Prostate kallikrein allergen
#471ANIMAL MODELS AND THERAPEUTIC MOLECULES
#472Compositions with reduced dimer formation
#473Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#474TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
#475Immune modulation
#476MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
#477Prefilled medication device, method of making and using the same
#478Glycotargeting therapeutics
#479Vaccine composition containing synthetic adjuvant
#480Dose selection of adjuvanted synthetic nanocarriers
#481Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#482Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#483Process for producing an allergen extract
#484Human antibodies to fel d1 and methods of use thereof
#485METHOD FOR DELIVERY OF IMMUNOMODULATORS TO A PATIENT
#486Induction of antigen-specific tolerance by peripheral phagocytosis
#487Modular antigen transportation molecules and uses therof
#488Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
#489Modification of Allergens for Immunotherapy
#490Lipid vesicle compositions and methods of use
#491Allergoids derived from allergenes
#492Compositions for Immunotherapy
#493Cladosporium peptides
#494Compositions and methods relating to the treatment of diseases involving TH1 and TH2/TH17
#495Peptide conjugated particles for the treatment of allergy
#496Compounds and methods for modulating pharmacokinetics
#497Compositions and methods for modulating immune responses
#498Immunoregulatory vaccine
#499CULTURED MYELOID DENDRITIC CELLS ISOLATED FROM PEYERS PATCHES AND USES THEREOF
#500Hypo-allergenic cross-linked proteins for use in the prevention of an allergy against milk-proteins and for use in the induction of oral tolerance
#501Polypeptides for use in the Prophylactic Treatment of Allergic Asthma
#502HYPOALLERGENIC FOOD-GRADE PROTEIN MATRICES AND USES THEREOF
#503Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen
#504COMPOSITIONS FOR TREATING AN INTESTINAL INFLAMMATORY CONDITION
#505COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#506Materials and methods for modulating immune responses
#507METHODS OF DEPOSITING PARTICLES OF A SUBSTANCE IN A TISSUE
#508Orally dissolving thin films containing allergens and methods of making and use
#509Cytokine-based fusion proteins for treatment of immune disorders
#510Modular nanodevices for smart adaptable vaccines
#511PHARMACEUTICAL COMPOSITION COMPRISING A POLYMERIC CARRIER CARGO COMPLEX AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN
#512Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy
#513T cell epitopes from Cockroach and methods of making and using same
#514Method for presymptomatic diagnosis of coeliac disease and gluten sensitivity
#515HOUSE DUST MITE ALLERGEN
#516ANTI-ALLERGIC MEDICAMENT
#517Allergy inhibitor compositions and kits and methods of using the same
#518Method for reducing the allergenicity of animal dander
#519VARIANTS OF GROUP 6 ALLERGENS OF THE TRUE GRASSES HAVING REDUCED ALLERGENEITY DUE TO MUTAGENESIS OF PROLINE RESIDUES
#520Subunit vaccine delivery platform for robust humoral and cellular immune responses
#521DNA sequence, and recombinant preparation of the grass pollen allergen Lol p 4
#522Contiguous Overlapping Peptides for Treatment of House Dust Mites Allergy
#523Animal models and therapeutic molecules
#524Long term disease modification using immunostimulatory oligonucleotides
#525EPITOPES FROM ALLERGEN PROTEINS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATION
#526METHOD OF PREVENTING ALLERGIES
#527SUBLINGUAL IMMUNOTHERAPY WITH REDUCED ORAL ITCHINESS
#528Modified epitopes for boosting CD4+ T-cell responses
#529Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
#530Methods of using a vaccine composition containing synthetic adjuvant
#531PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS
#532NON-DIGESTIBLE OLIGOSACCHARIDES FOR ORAL INDUCTION OF TOLERANCE AGAINST DIETARY PROTEINS
#533T-CELL ANTIGEN PEPTIDE FROM ALLERGEN FOR STIMULATION OF IL-10 PRODUCTION
#534IMMUNOGENIC GLUTEN PEPTIDES AND USES THEREOF
#535Induction of mucosal tolerance to antigens
#536Fusion proteins representing different allergens and a vaccine against allergy to mites
#537Induction of mucosal tolerance to antigens
#538Beta-lactoglobulin peptides for treating cow's milk protein allergy
#539Vaccine adjuvant composition comprising inulin particles
#540Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
#541Immunogenic protein Pas n 1 from Bahia grass pollen
#542PEPTIDES FOR VACCINE
#543ALLERGENS FROM INSECTS
#544Manufacture of peanut formulations for oral desensitization
#545Lipid vesicle compositions and methods of use
#546Allergen dosage form
#547Peanut formulations and uses thereof
#548Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity
#549Prostate kallikrein allergen
#550Programming of cells for tolerogenic therapies
#551Method for the production of hydrolyzed allergens
#552Methods for Effectively and Rapidly Desensitizing Allergic Patients
#553Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#554Allergen peptide fragments and use thereof for treatment of dust mite allergies
#555PEPTIDE FOR VACCINE
#556SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION
#557Animal models and therapeutic molecules
#558Animal models and therapeutic molecules
#559RNA Vaccines
#560MUCOSOMAL ALLERGEN-SPECIFIC IMMUNOTHERAPY WITH INITIAL DOSING AFTER START OF POLLEN SEASON
#561Animal models and therapeutic molecules
#562Zwitterionic immunomodulators for the treatment of asthma and allergy
#563Treatment for peanut allergy
#564Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance
#565Vaccine peptide combinations
#566Vaccine composition containing synthetic adjuvant
#567SUPPRESSION OF A HYPERSENSITIVITY IMMUNE RESPONSE WITH UNRELATED ANTIGEN DERIVED FROM ALLERGEN SOURCE MATERIAL
#568Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof
#569MODULATION OF EFFECTOR T CELL RESPONSES BY LOCAL DEPLETION OF COMPLEMENT COMPONENT C3
#570PEPTIDE WITH REDUCED DIMER FORMATION
#571Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus
#572Animal models and therapeutic molecules
#573Hypoallergenic polypeptides for the treatment of house dust mite allergy
#574Modulation of antigen immunogenicity by addition of epitopes recognized by NKT cells
#575Methods and compositions for dosing of allergens
#576DERMATOPHAGOID PTERONYSSINUS (DER P1) ANTIGEN EPITOPE AND ANTI-DER P1 ANTIBODY
#577Human antibodies to Fel d1 and methods of use thereof
#578Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
#579Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
#580Microbial delivery system
#581Peptides for vaccine against birch allergy
#582Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
#583Allergy inhibitor compositions and kits and methods of using the same
#584Composition and method for inducing antigen-specific tolerance using IgA
#585SUPPRESSION OF A TYPE 1 HYPERSENSITIVITY IMMUNE RESPONSE WITH AN UNRELATED ANTIGEN
#586Compositions and methods for inducing immune tolerance
#587Methods, articles and kits for allergic desensitization, via the oral mucosa
#588Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
#589MICROBIAL DELIVERY SYSTEM
#590Compositions for inhibiting gene expression and uses thereof
#591Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
#592Immunostimulating Polyphosphazene Compounds
#593Vaccine composition containing synthetic adjuvant
#594METHODS OF TREATING ALLERGIES WITH SUBSTANTIALLY PHENOL-FREE CARRIERS
#595Methods of using a vaccine composition containing synthetic adjuvant
#596Allergen
#597Transgenic mouse homozygous for chimeric IgH locus
#598ADJUVANT CONTAINING beta-HEMATIN
#599Mutant CTAI fusion protein for treatment of allergy and autoimmune disease
#600TREATMENT AND/OR PREVENTION OF ORAL ALLERGIC SYMPTOMS CAUSED BY ORAL CONTACT WITH FRUITS AND/OR VEGETABLES